A review of tigecycline resistance in nontuberculous mycobacteria
Camila da Silva Moura, William Marco Vicente da Silva, Jesus Pais Ramos · 2026
Read A review of tigecycline resistance in nontuberculous mycobacteria by Camila da Silva Moura, William Marco Vicente da Silva, Jesus Pais Ramos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13616840.txt.
Description
Camila da Silva Moura, with William Marco Vicente da Silva and Jesus Pais Ramos, reviews how nontuberculous mycobacteria resist tigecycline, an antibiotic used against these hard-to-treat pathogens. Nontuberculous mycobacteria live in soil and water and cause chronic lung disease, mostly in people with weak immune systems or damaged lungs. Their review gathers twenty-eight studies on resistance mechanisms and on how common resistance is.
The data show tigecycline is less affected by MabTetX, the main tetracycline resistance factor in Mycobacterium abscessus, than older drugs are. Other pathways still raise the dose needed to stop growth, including efflux pumps that push the drug out and changes in stress-response controls. Slow-growing species such as Mycobacterium avium stay poorly susceptible. The authors conclude tigecycline fits best in combination regimens for fast-growing species, and they note that standard breakpoints for testing are still missing.
Catalog record
| CREATOR | Camila da Silva Moura, William Marco Vicente da Silva, Jesus Pais Ramos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |